SEP 8, 2026 · PHASE 3 TRIAL
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
ClinicalTrials.gov
This is a clinical trial registry record describing a Phase 3 RCT that is currently recruiting with no results posted; the study design is rigorous but outcomes are not yet available.
Reported
Planned sample size558
PhasePHASE 3
Primary endpoint 1Progression-Free Survival (PFS) as Assessed…